Evidence map›Paper›PMID 32034295›Full record

Observational studySpinal cord2020

The safety and feasibility of a new rehabilitation robotic exoskeleton for assisting individuals with lower extremity motor complete lesions following spinal cord injury (SCI): an observational study.

Xiao-Na Xiang, Ming-Fu Ding, Hui-Yan Zong, Yan Liu, Hong Cheng, Cheng-Qi He, Hong-Chen He

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Spinal cord, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao-Na Xiang *Rehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.ORCID http://orcid.org/0000-0001-8659-1080
Ming-Fu Ding *Rehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Hui-Yan ZongRehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Yan LiuRehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China.
Hong ChengUniversity of Electronic Science and Technology of China, Chengdu, 611731, Sichuan, PR China.
Cheng-Qi HeRehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China. hxkfhcq@126.com.
Hong-Chen HeRehabilitation Medicine Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, PR China. xiaohe0613@foxmail.com.

Funding

Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2017YFB1302305
6 · The paper itself

Abstract

STUDY

designA pre-post observational study.

objectivesTo evaluate the safety and feasibility of a new rehabilitation robotic device for assisting individuals with lower extremity motor complete lesions following spinal cord injury (SCI).

settingThree hospitals in Sichuan Province, China.

methodsIndividuals aged 15-75 years with an SCI between vertebrae six (T6) and lumbar 1 (L1) and complete motor paralysis participated in an exoskeletal-assisted walking (EAW) programme (2 weeks, 5 days/week, 30 min/day). Data were collected pre-, mid- (week 1) and post-intervention (week 2).

resultsTwenty-eight individuals (mean age = 41.3, 71% males) participated in the EAW programme. The distance walked during the 6-min walking test (6MWT) increased relative to that at baseline, during week 1 (13.0 ± 5.3 m) and week 2 (16.2 ± 5.3 m) when wearing the exoskeleton. The walking speed during the 10-m walking test (10MWT) increased from 0.039 ± 0.016 to 0.045 ± 0.016 m/s. The Hoffer walking ability grade, the Spinal Cord Independence Measure (SCIM), and the Walking Index for SCI II (WISCI II) changed after 2 weeks of EAW. No improvement in lower extremity motor score (LEMS) was observed. The rates of adverse events and serious adverse events were 21% and 4%, respectively.

conclusionsThe EAW programme with the new robotic exoskeleton provided potential meaningful improvements in mobility for individuals with SCI and had few adverse events.

Indexed as

Exercise TherapyExoskeleton DeviceNeurological RehabilitationOutcome and Process Assessment, Health CareWalkingAdolescentAdultAgedFeasibility StudiesFemaleHumansMaleMiddle AgedParaplegiaProgram EvaluationSpinal Cord Injuries

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.